Beryl Drugs Ltd (524606)

Beryl Drugs Ltd recorded two insider trading transactions during the past ninety days, both involving net purchases by Sudhir Sethi. These acquisitions totaled 128,228 INR, representing approximately 0.0017% of the float. The stock price increased 17.4% over this period, while no recent earnings report data is currently available for the firm.
Ticker: 524606 Exchange: BSE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 9 Jun 2026
Value ₹3,215,693.00 | Price 194.62 | Shares 70,574
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-10 2026-06-09 B Purchase Director Large shareholder
70,574
194.62
₹3,215,693
70,574 194.62 ₹3,215,693
2026-06-07 2026-06-05 B Purchase Director Large shareholder
79,233
332.61
₹4,089,486
79,233 332.61 ₹4,089,486
2023-03-14 2023-03-13 S Sale Through TARA SETHI, a person closely affiliated to an insider Director
4,850
363.11
₹3,103,868
4,850 363.11 ₹3,103,868
2023-03-14 2023-03-13 B Purchase SUDHIR SETHI Large shareholder
74,104
0.00
₹0
74,104 0.00 ₹0
2021-09-23 2021-06-04 B Purchase SANJAY SETHI Revised Director Large shareholder
7,500
0.00
₹0
7,500 0.00 ₹0
2021-09-23 2021-06-04 S Sale BABULAL SETHI Large shareholder
7,500
0.00
₹0
7,500 0.00 ₹0